The latest medical news on transthyretin amyloidosis
Online version
ATTR Expert
Tuesday January 07, 2025
ATTR Expert
Hello     ,
Below, you will find the latest scientific news regarding transthyretin amyloidosis, sourced from the most prestigious peer-reviewed journals.
News

Prognostic implication of DPD quantification in transthyretin cardiac amyloidosis
European heart journal cardiovascular Imaging 2024; aop: 10.1093/ehjci/jeae295 |  René Rettl et al.
Quantification of cardiac [Tc]-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake enhances diagnostic capabilities and may facilitate prognostic stratification in patients with transthyretin cardiac...
READ MORE +

A functional role for spontaneously occurring natural anti‐transthyretin antibodies from patients with transthyretin cardiac amyloidosis
European Journal of Heart Failure 2024; AOP: 10.1002/ejhf.3527 |  Ortal Tuvali et al.
Transthyretin cardiac amyloidosis (ATTR‐CA) is a progressive disease that results from the accumulation of transthyretin (TTR) fibrils in the extracellular space of the myocardium, leading to heart...
READ MORE +

Wild‐type transthyretin cardiac amyloidosis and aortic stenosis: Can carpal tunnel syndrome help distinguish the chicken from the egg?
Journal of Internal Medicine 2024; AOP: 10.1111/joim.20042 |  Marc‐Antoine Delbarre et al.
Wild‐type transthyretin amyloidosis (ATTRwt) is a systemic disorder characterized by the pathological accumulation in various organs of insoluble amyloid fibrils composed of misfolded wild‐type...
READ MORE +
Bibliographic data :  News  |  Archives  |  Highlight  |  My bibliography
Useful links:  Homepage  |  Bibliographic research
GNM Healthcare
Copyright 2025 © GNM Healthcare Consulting France SAS
With the institutional support of Alnylam Pharmaceuticals
Inform/Invite a colleague  | My account  | Delete my data
By requesting access to the "ATTR Expert" service, I agree that GNM Healthcare Consulting France SAS may use the data acquired during my access request to provide me with twice per month information related to its services in accordance with the Privacy Policy.
You have the right to access, rectify and delete your data, which you can exercise by sending your request to dpo@gnmhealthcare.com. You can exercise your right to object by requesting the deletion of your data at any time by clicking on the "Delete my data" link.